Trial Information
Exercise During Chemotherapy for Patients With Hematological Malignancies
Inclusion Criteria:
- Hematological malignant disease
- Current chemotherapy
- Understanding of written German
Exclusion Criteria:
- Cardiorespiratory, metabolical, osteoarticular or immunological disorders which can
be aggravated by exercise
- Pathological stress-ECG at recruitment
Type of Study:
Interventional
Study Design:
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator)
Outcome Measure:
Fatigue
Outcome Time Frame:
At recruitment and after 12 weeks
Safety Issue:
No
Principal Investigator
Fernando Dimeo, MD
Investigator Role:
Principal Investigator
Investigator Affiliation:
Charite University, Berlin, Germany
Authority:
Germany: Ethics Commission
Study ID:
EA4/031/09
NCT ID:
NCT00884364
Start Date:
May 2009
Completion Date:
September 2011
Related Keywords:
- Hematological Diseases
- Hematological Malignancies
- Lymphoma
- Leukemia
- Multiple myeloma
- Hodgkin´s disease
- Exercise
- Sport
- Fatigue
- Hematological neoplastic diseases
- Neoplasms
- Hematologic Diseases
- Hematologic Neoplasms